Resmed Inc (RMD) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Resmed Inc   (NYSE: RMD)
 

Resmed Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RMD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 8.67 % 8.19 % 10.18 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) -1.49 % -2.57 % -2.46 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 9.93 % 7.23 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 2.04 % 1.81 % 2.1 % 2.61 %
Revenue 5 Year Average Growth 4.63 % 10.55 % 8.67 % 13.63 %


RMD's Growth Comparisons in I. Quarter 2026




Resmed Inc 's 8.67% year on year top-line increase in the first quarter 2026 to 1.44 billions, decelerating from Resmed Inc 's growth trends, but compares favorably to the 8.19% growth in the Medical Equipment & Supplies industry, but Resmed Inc 's growth compares unfavorably, to the 10.18% Revenue improvement in the Healthcare sector.

Top-line fell by -1.49% from the fourth quarter. Average annual sales growth for Resmed Inc is 4.63%, while S & P 500's average yearly sales increase is 13.63%, including only Businesses with the first quarter 2026 financial results.

RMD Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Sleep and Breathing Health
7.73 %
-74.69 %
Residential Care Software
-6.7 %
-77.06 %
Devices
-
-35.94 %
Masks and Other
-
-5.7 %
Americas
-
-
Rest of World
-
-
Total
8.67 %
-1.49 %


Growth Rates of RMD's Income in the first quarter 2026


RMD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 1.44 % 11.57 % 11.09 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) 0.95 % 101.75 % -12.21 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) 8.52 % 13.88 % 30.98 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) 0.34 % 3.53 % 4.93 % 20.86 %
Operating Income 5 Year Avg. Change 15.86 % 11.5 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 20.05 % -73.24 % -38.86 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) 9.12 % 25.09 % -63.27 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 10.8 % 80.61 % 9.88 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) 4.59 % -1.66 % -4.67 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 26.27 % 5.35 % 8.91 % -28.64 %

RMD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 20.05 % -74.33 % -39.2 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) 9.12 % 44.21 % 11.78 % 27.07 %
Y / Y Net Income Change (Q3 TTM) 10.8 % -0.43 % 15.43 % 57.33 %
Sequential Net Income Change (Q3 TTM) 4.59 % -3.35 % -6.73 % 18.65 %
Net Income 5 Year Avg. Growth 26.27 % 4.12 % 9.09 % 23.95 %

RMD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 23.11 % -76.12 % -38.86 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) 11.41 % -63.27 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 12 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) 5.27 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 26.21 % -3.12 % 8.91 % -28.64 %



RMD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 23.21 % -77.09 % -39.2 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) 11.03 % 11.78 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) 5.28 % - 10.63 % 4.93 %
EPS Net 5 Year Avg. Change 26.34 % 4.12 % 9.09 % 23.95 %



Resmed Inc showed impressive 23.21% year on year rise in the first quarter to $2.92, despite the -77.09% inMedical Equipment & Supplies industry, Healthcare sector dropped -39.2%. Slow first quarter 2026 income per share, in Medical Equipment & Supplies industry and Healthcare sector, were portrayed in the Resmed Inc results which underperformed overall market.

The bottom-line improved by 11.03% from the fourth quarter. Looking into annual income per share rise of 26.34%, and S & P 500's average yearly income per share growth is 23.95% over the five years, including only Businesses with the first quarter 2026 earnings reports. Resmed Inc grew faster than the market.

RMD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -9.2 % 47.11 % 44.26 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) -7.22 % -58.13 % -42.65 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) -8.53 % 44.19 % 19.33 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) -2.3 % 9.4 % 5.88 % 15.75 %
Free Cash Flow 5 Year Avg. Change 21.59 % 4.15 % 0.41 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) -71.11 % - - 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - -9.69 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 6.47 % 4.57 % 10.33 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) -6.03 % -21.9 % -19.32 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) 29.54 % 1.49 % 9.34 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) 1.84 % -1.72 % 0.99 % 23.05 %
Capital Expenditures 5 Year Avg. Change 6.29 % 8.29 % 8.61 % 14.19 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.